ArticleEuropean journal of nuclear medicine and molecular imaging2016

Extent of disease in recurrent prostate cancer determined by [(68)Ga]PSMA-HBED-CC PET/CT in relation to PSA levels, PSA doubling time and Gleason score.

Frederik A Verburg et al.PubMed ↗Publisher ↗

No numbers read from the abstract.